A number of Indian companies are planning to invest in pharmaceutical sector in Afghanistan after the air fright corridor opened between Kabul and New Delhi last week.
“A contract or protocol is under processing which will be completed in three phases. Indian pharmaceutical companies would like to invest jointly in Afghanistan,” said Khan Jan Alokozay, deputy of Afghanistan’s Chamber of Commerce and Industries.
The official added that about 40 tons of medicines were imported to Afghanistan from India after the direct route opened between the two countries on June 21.
Reports also suggest that the government of Afghanistan has decided to buy medicines for the Afghan national security forces from the Indian companies.
Afghan ministry of public health praises the move by the Afghan and Indian companies.
“The medicines prices will be cheaper and will have a high quality as well, the air fright corridor was another step toward the implementation of this plan,” said Muhibullah, head of the curative section of the health ministry.
This comes as about 11 pharmaceutical companies are operating in Afghanistan right now and have invested around $50 million in the industry.